Urologix, Inc. (ULGX) Reports Q2 Loss of $0.09
Tweet
Share
E-mailGet Alerts ULGX Hot Sheet
Price: $0.00 --0%
Financial Fact:
Total operating expense: 1.46M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expense: 1.46M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Urologix, Inc. (NASDAQ: ULGX) reported Q2 EPS of ($0.09), versus ($0.04) reported last year. Revenue for the quarter came in at $2.92 million, versus $3.26 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
